Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
State health officials are investigating possible sources of the H5 avian influenza virus detected for the first time in a wastewater sample from Oahu, but reassure residents that public risk remains ...